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ABSTRACT
A balanced supply of deoxyribonucleoside
triphosphates (dNTPs) is one of the key prerequi-
sites for faithful genome duplication. Both the
overall concentration and the balance among the
individual dNTPs (dATP, dTTP, dGTP, and dCTP)
are tightly regulated, primarily by the enzyme
ribonucleotide reductase (RNR). We asked whether
dNTP pool imbalances interfere with cell cycle pro-
gression and are detected by the S-phase check-
point, a genome surveillance mechanism activated
in response to DNA damage or replication blocks.
By introducing single amino acid substitutions
in loop 2 of the allosteric specificity site of
Saccharomyces cerevisiae RNR, we obtained a col-
lection of strains with various dNTP pool imbal-
ances. Even mild dNTP pool imbalances were
mutagenic, but the mutagenic potential of different
dNTP pool imbalances did not directly correlate with
their severity. The S-phase checkpoint was
activated by the depletion of one or several dNTPs.
In contrast, when none of the dNTPs was limiting for
DNA replication, even extreme and mutagenic dNTP
pool imbalances did not activate the S-phase
checkpoint and did not interfere with the cell cycle
progression.
INTRODUCTION
Accurate duplication of DNA is indispensible for the
maintenance of genome integrity. The four deoxyribo-
nucleoside triphosphates (dNTPs) are the precursors for
DNA synthesis. Because dNTP pool imbalances are
mutagenic, the concentration of dNTPs is tightly con-
trolled (1,2). Most of dNTP pool imbalances are
detected by the cell. An increase in the concentration of
one dNTP usually results in depletion of another dNTP,
which in turn leads to the inhibition of DNA replication
and to activation of the S-phase checkpoint, a genome
surveillance mechanism. The activated S-phase checkpoint
arrests cell cycle progression, stabilizes replication forks
and activates DNA repair (3). In higher eukaryotes the
activated checkpoint can lead to apoptosis. However, it
is not known whether the dNTP pool imbalances that
do not result in a depletion of one or several dNTPs inter-
fere with DNA replication or lead to the activation of the
S-phase checkpoint. If undetected, such dNTP pool imbal-
ances may lead to higher mutation rates, genomic insta-
bility and development of cancer.
dNTP pool imbalances can be brought about by muta-
tions aﬀecting the allosteric regulation of the enzymes
involved in dNTP biosynthesis: CTP synthetase (4),
dCMP deaminase (5,6), or ribonucleotide reductase
(RNR) (6). Mutations in these enzymes were obtained in
cultured Chinese Hamster ovary cells or S49 mouse
lymphosarcoma cells after lengthy selections for resistance
to inhibitory concentrations of various nucleosides or
their analogues. It is therefore conceivable that the
S-phase checkpoint or other putative surveillance mecha-
nisms that could be involved in monitoring of the dNTP
pool quality are defective in such cells.
To investigate how dNTP pool imbalances aﬀect cell
cycle progression and checkpoint activation in a
checkpoint-proﬁcient eukaryotic cell, we decided to
perturb the dNTP pool in yeast Saccharomyces cerevisiae
by introducing mutations in the allosteric speciﬁcity site
of RNR. RNR catalyses the rate-limiting step in the pro-
duction of all four dNTPs required for the synthesis
of nuclear and mitochondrial DNA (1,7). Eukaryotic
RNRs reduce NDPs to corresponding dNDPs, which
are then phosphorylated to dNTPs. Yeast RNR is
encoded by four genes. RNR1 and RNR3 encode the
large subunit (8,9). RNR3 is a non-essential paralogue of
RNR1, and is normally expressed at very low levels, but is
highly induced after DNA damage due to the activation of
the S-phase checkpoint (8). The Rnr3 protein has a low
catalytic activity, can form a heterodimer with Rnr1 (10),
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RNR2 and RNR4 encode the small subunit of RNR
(11–14), a heterodimer that harbours the tyrosyl radical
crucial for catalysis (15–18).
The crystal structure of yeast Rnr1 was recently solved
by Dealwis and co-workers (19) as a dimer. Each Rnr1
contains one catalytic site and two allosteric sites
(Figure 1A). The allosteric activity site regulates the
total dNTP pool size by monitoring the dATP/ATP
ratio, while the allosteric speciﬁcity site regulates the
balance among the four dNTPs (20). Binding of dATP
or ATP to the speciﬁcity site selects for the reduction of
UDP and CDP, binding of dTTP selects for the reduction
of GDP and binding of dGTP selects for the reduction
of ADP (20).
The allosteric speciﬁcity site in all crystallized RNRs is
proposed to be organized by two loops, called loop 1 and
loop 2 (Figure 1A), which are ordered only in the presence
of a speciﬁcity eﬀector (19,21–23). The crystal structures
of RNR in complex with four cognate allosteric speciﬁcity
eﬀector–substrate pairs suggest the molecular mechanism
of substrate speciﬁcity regulation (19,23). Loop 1 interacts
only with eﬀectors bound at the speciﬁcity site, while loop
2 interacts with the bases of both eﬀectors and substrates
and provides speciﬁcity by adopting unique conforma-
tions for each eﬀector–substrate pair.
Each species has its own balance of the four dNTPs. In
logarithmically growing wild-type yeast cells, the S-phase
concentration of dTTP is  2-fold higher than the concen-
trations of dCTP and dATP, and  4-fold higher than the
concentration of dGTP (24). The amounts of individual
dNTPs present in a cell are not proportional to the total
amount of the corresponding bases in the yeast genome
(Figure 1B). dNTP production is tightly coupled to utili-
zation, and the minute amounts of individual dNTPs
present in S-phase at any given moment are only enough
for the synthesis of a small fraction of the genome
(Figure 1B). For example, the amount of dGTP present
in S-phase of a yeast cell is enough for the synthesis of
only  4% of genome’s G bases.
Here, we demonstrate that diﬀerent single amino acid
substitutions in loop 2 of yeast RNR lead to deﬁned and
diﬀerent dNTP pool imbalances in vivo. We take advan-
tage of this fact to investigate the extent to which system-
atic variations in dNTP levels aﬀect cellular rates of
proliferation and mutagenesis. The results reveal a ﬁne
balance between the cellular dNTP concentrations, the
S-phase checkpoint response and DNA replication
ﬁdelity.
MATERIALS AND METHODS
Plasmids and yeast strains
To facilitate RNR1 mutagenesis, we ﬂanked loop 2 in the
pESC-URA-RNR1 plasmid by unique endonuclease
restriction sites for BssHII and KasI without changing
the Rnr1 amino acid sequence (Supplementary Figure
S1). The TRP1 selection marker was introduced after
the RNR1 gene. The wild-type loop 2 sequence was
excised with BssHII and KasI and the digested vector
was ligated with chemically synthesized loop 2 containing
the desired mutations (Supplementary Table S1). The
presence of mutations was conﬁrmed by sequencing. The
pESC-URA-rnr1-D287N and pESC-URA-rnr1-D287A
plasmids were constructed by the modiﬁcation of
pESC-URA-RNR1 plasmid using QuikChange
TM
Site-directed mutagenesis kit (Stratagene) and the corre-
sponding primers (Supplementary Table S2).
All yeast strains used in this study are isogenic to
W4069-4C (24). Supplementary Table S3 gives only the
allele(s) that diﬀer from the W4069-4C genotype. To
replace the wild-type RNR1 gene with the mutant alleles,
the 2m origin in the pESC-URA-rnr1 plasmids was
removed as described before (25), the plasmids were
linearized with BstEII and integrated by homologous
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Figure 1. RNR regulation and dNTP pools in S. cerevisiae.( A)
Schematic representation of yeast RNR. The large subunit is an
Rnr1 dimer, the small subunit is an Rnr2/Rnr4 heterodimer,
although higher order complexes may also exist. Rnr3 (not shown) is
a non-essential DNA-damage-inducible Rnr1 paralogue, which can
form Rnr3 homodimers or heterodimers with Rnr1. The speciﬁcity
eﬀectors contact both loop 1 (blue) and loop 2 (green), while the
substrates contact only loop 2. The speciﬁcity information is transmit-
ted to the catalytic sites (red) via loop 2. (B) The approximate number
of dNTP molecules present at any given moment in S-phase (S) and the
total number of dNTP molecules required for the duplication of the
yeast nuclear DNA (T). Numbers above the bars indicate the S/T ratios
in percent.
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strain. BstEII cuts RNR1 738bp before the loop 2
sequence. The correct integration was conﬁrmed by
sequencing. The resulting strains contain an rnr1 mutant
allele under the wild-type RNR1 promoter, the
pESC-URA backbone sequence and the wild-type RNR1
gene under GAL1 promoter, which is repressed in
glucose-containing media.
Strains with the plasmids expressing wild-type or
mutant RNR1 were grown in synthetic complete media
without uracil (SC-URA) with 2% dextrose or galactose.
Strains with the integrated mutant rnr1 alleles were grown
in YPAD media (1% yeast extract, 2% bacto-peptone,
250mg/l adenine, 2% dextrose, 2% agar for plates).
Flow cytometry analysis was done as described (26).
Determination of dNTP and NTP pools
At a density from 0.4 10
7 to 0.5 10
7 cells/ml,
 3.70 10
8 (as determined by OD600) cells were harvested
by ﬁltration through 25mm White AAWP nitrocellulose
ﬁlters (0.8mm, Millipore AB, Solna, Sweden). To deter-
mine the exact number of cells, the cells were also
counted in hemocytometer. The ﬁlters were immersed in
700ml of ice-cold extraction solution (12% w/v
trichloroacetic acid, 15mM MgCl2) in Eppendorf tubes.
The following steps were carried out at 4 C. The tubes
were vortexed for 30s, incubated for 15min and
vortexed again for 30s. The ﬁlters were removed and the
700ml supernatants were collected after centrifugation at
20000g for 1min and added to 800ml of ice-cold Freon–
trioctylamine mixture [10ml of Freon
(1,1,2-trichlorotriﬂuoroethane), Aldrich, Sigma-Aldrich
Sweden AB, Stockholm, Sweden, 99% and 2.8ml of
trioctylamine, Fluka, Sigma-Aldrich Sweden AB,
Stockholm, Sweden, >99%]. The samples were vortexed
and centrifuged for 1min at 20000g. The aqueous phase
was collected and added to 700ml of ice-cold Freon–
trioctylamine mixture. 475 and 47.5ml of the aqueous
phase were collected. The 475ml aliquots of the aqueous
phase were pH adjusted with 1M NH4HCO3 (pH 8.9),
loaded on boronate columns [Aﬃ-Gel 601 (Bio-Rad)]
and eluted with 50mM NH4HCO3, pH 8.9, 15mM
MgCl2 to separate dNTPs and NTPs. The eluates with
puriﬁed dNTPs were adjusted to pH 3.4 with 6M HCl,
separated on a Partisphere SAX-5 HPLC column
(4.6 12.5cm, PolyLC Inc., Columbia, MD, USA) and
quantiﬁed using a UV-2075 Plus detector (Jasco,
Mo ¨ lndal, Sweden). Nucleotides were isocratically eluted
using 0.36M ammonium phosphate buﬀer (pH 3.4,
2.5% v/v acetonitrile). The 47.5ml aliquots of the
aqueous phase were adjusted to pH 3.4 and used to
quantify NTPs by HPLC in the same way as dNTPs.
Calculation of the dNTP molecules
Saccharomyces cerevisiae genome contains 12.1 10
6bp
and requires 24.2 10
6 dNTPs for its duplication. The
percentages of A, T, G and C in the yeast genome are
31, 31, 19 and 19%, respectively. Therefore, the number
of dATP, dTTP, dGTP and dCTP molecules required for
one round of replication is 7.5 10
6, 7.5 10
6, 4.6 10
6
and 4.6 10
6, respectively. There is  35 pmol of dATP
present in 10
8 logarithmically growing cells (Figure 3B), or
35 10
 20mol of dATP per cell, which corresponds to
0.21 10
6 molecules per cell. Because the concentration
of dNTPs in S phase is  2-fold higher than the concen-
tration of dNTPs in logarithmically growing cells, an
estimated number of dATP molecules present at any
given moment in an S-phase cell is 0.4 10
6. The
numbers of dTTP, dGTP and dCTP molecules present
in an S-phase cell (1.0 10
6, 0.2 10
6 and 0.5 10
6,
respectively) were calculated in the same way as for
dATP. These numbers were used to calculate the percent-
ages of dNTP shown in Figure 1B.
Measurement of mutation rates
Eight independent cultures from two diﬀerent isolates of
each strain were grown in YPAD complete media until
saturation. Cells were then washed twice with sterile
water and the appropriate dilutions were plated on syn-
thetic complete medium lacking arginine and containing
60mg/ml of L-canavanine (SC-Arg + Can) to score the
Can
r colonies and on complete media (YPAD) plates to
count viable cells. The plates were incubated for 3–5 days
at 30 C before counting. The frequency of forward
mutation to Can
r at the CAN1 locus was calculated by
dividing the number of Can
r colonies by the viable cell
count. Mutation rates were calculated from the
frequencies as described previously (27). Statistical
analyses to determine the 95% conﬁdence limits for
the median and the signiﬁcance of the diﬀerences
between the mutation rates (Wilcoxon–Mann–Whitney
non-parametric test) were done as described in Ref. (28).
Western blotting
The protein extracts were made as described (29). For
Rnr2 and Rnr3 detection, aﬃnity puriﬁed polyclonal
anti-Rnr2 and anti-Rnr3 antibodies were used at 1:500
000 and 1:1000 dilutions, respectively. For detection of
both Rnr4 and a-tubulin, YL1/2 rat monoclonal
antibodies (Sigma) were used at 1:2500 (30).
RESULTS
Mutations in loop 2 of Rnr1 lead to imbalanced dNTP
pools
The amino acid sequence of loop 2 is conserved among
species (Figure 2A). It was possible that all changes in
loop 2 would abolish RNR activity or completely
disrupt the allosteric speciﬁcity regulation, and thereby
have similar eﬀects on cellular dNTP levels. To initially
determine whether diﬀerent mutations in loop 2 lead to
diﬀerent dNTP pool imbalances, we overexpressed Rnr1
proteins with substitutions in residues Y285, D287, Q288
or R293 of loop2, and measured the resulting dNTP
pools. We chose these residues either because they are
conserved and/or because structural studies showed that
they are involved in important interactions with the
eﬀectors or substrates in yeast RNR as demonstrated by
Dealwis and co-workers (19). Overexpression of rnr1
Nucleic Acids Research, 2010,Vol.38, No. 12 3977alleles with mutations in loop 2 using an inducible GAL1
promoter (Figure 2B) resulted in unique new dNTP pool
balances (Figure 2C). These were diﬀerent from the dNTP
pool balance observed in the cells with an overexpressed
wild-type RNR1 gene, which resulted in a  9–10-fold
increase in all 4 dNTPs (25). The results in Figure 2C
indicate that each substitution in loop 2 changed the
allosteric speciﬁcity regulation in a distinctive way. In all
strains with overexpressed rnr1 mutants, the individual
dNTP concentrations were higher than in the wild-type
cells, except for dCTP in the rnr1-Q288A-overexpressing
strain, which was  20% below wild-type levels. The
largest increase for pyrimidine dNTPs was observed in
the rnr1-Y285A strain (55-fold for dCTP and 33-fold for
dTTP) and the largest increase for purine dNTPs was in
the rnr1-Q288A strain (14-fold for dATP and 63-fold for
dGTP).
Continuous expression of RNR1 from the GAL1
promoter induces the increased dNTP concentrations
outside of S-phase, which might interfere with cell cycle
progression and DNA damage checkpoint activation (25).
Also, overproduction of Rnr1 protein (Figure 2B) could
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Figure 2. Overexpression of loop 2 rnr1 mutants leads to imbalanced dNTP pools. (A) Sequence alignment of loop 2 in RNRs from diﬀerent
organisms. Numbering is according to yeast Rnr1. The residues mutated in this study are boxed. (B) Incubation of yeast strains harbouring the
indicated plasmids in SC – URA + GAL media for 3h results in overexpression of Rnr1 proteins. (C) dNTP pools in the wild-type strain grown in
SC + GLU media (28 pmol dCTP, 62 pmol dTTP, 51 pmol dATP and 15 pmol dGTP per 10
8 cells) and mutant strains grown in SC – URA +
GAL media for at least six generations. Two independent isogenic strains for each genotype were analysed. Data are represented as mean±SD.
Numbers above the bars indicate fold-increase (green) or fold-decrease (red) of the dNTP concentration relative to wild-type.
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Therefore, we replaced the endogenous RNR1 by the rnr1
mutant alleles and used the resulting strains in all subse-
quent studies. We were unable to obtain viable haploid
yeast cells harbouring rnr1-D287N, rnr1-D287A and
rnr1-Q288E alleles, perhaps because the activity of the
corresponding Rnr1 proteins was too low. In all viable
strains with the integrated rnr1 mutants, the dNTP pools
were imbalanced (Figure 3B). In the strains harbouring
the rnr1-Q288A and rnr1-R293A alleles, the concentration
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Figure 3. Eﬀects of dNTP pool imbalances on cell cycle and proliferation. (A) Representative HPLC chromatograms demonstrating the OD260
absorbance of dNTPs in the wild-type (green), rnr1-Q288A (red) and rnr1-Y285A (blue) strains. Some of the dNTP peaks are invisible at this level of
magniﬁcation. (B) dNTP pools in the wild-type (41 pmol dCTP, 81 pmol dTTP, 35 pmol dATP and 15 pmol dGTP per 10
8 cells) and mutant strains
with the integrated rnr1 alleles grown in YPAD media. Two independent isogenic strains for each genotype were analysed. Data are represented as
mean±SD. Numbers above the bars indicate fold-increase (green) or fold-decrease (red) of the dNTP concentration relative to wild-type. (C) Flow
cytometry histograms for the strains indicated in (B). Peaks with less than G1 DNA content (prominent in rnr1-Q288A and rnr1-R293A and indicated
by brackets) represent dead cells and cell debris. (D) YPAD plates with strains indicated in (B). (E) Proliferation curves. Two independent isogenic
strains for each genotype were grown overnight in YPAD, re-inoculated into fresh YPAD at the OD600=0.1, the OD600 was measured every hour
and the values were plotted on log2 scale. Data are represented as mean±SD. The slow growing rnr1-Q288A and rnr1-R293A did not show any lag
phase as their overnight cultures did not reach the stationary phase. (F) Tetrad analysis demonstrating that rnr1-293A relies on RNR3 for survival.
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that utilization of these dNTPs was faster than their pro-
duction. The rnr1-Q288A strain had only  8% of the
normal dCTP concentration and the rnr1-R293A strain
had 36, 66 and 30% of the normal dCTP, dTTP and
dGTP concentrations, respectively. These results suggest
that the Rnr1-Q288A and Rnr1-R293A proteins can
provide suﬃcient RNR activity only when overexpressed
from the GAL1 promoter (Figure 2C). The rnr1-Y285A
strain had extremely high pyrimidine dNTP concentra-
tions (20-fold increased dCTP and 17-fold increased
dTTP), whereas the concentrations of the purine dNTPs
were close to normal (Figure 3B). These results demon-
strate for the ﬁrst time that it is possible to obtain yeast
strains with diﬀerent imbalanced dNTP pools by
introducing mutations in loop 2 of Rnr1.
Eﬀects of dNTP pool imbalances on cell cycle progression
The strains with the integrated rnr1-Q288A and
rnr1-R293A alleles had dNTP pools below their normal
level. In these two strains, the S-phase was signiﬁcantly
prolonged (Figure 3C) and the proliferation rate was
decreased (Figure 3D and E). We also observed a large
proportion of dead cells (Figure 3C).
The rnr1-R293A mutant was synthetic lethal with the
deletion of RNR3, encoding the alternative large RNR
subunit (Figure 3F). We were also not able to obtain
viable colonies after sporulating rnr1-Q288A rnr3D
diploids. These results suggest that the rnr1-R293A and
rnr1-Q288A strains rely on the non-essential Rnr3
protein for survival because the Rnr1-Q288A and
Rnr1-R293A proteins by themselves are not able to
support the production of suﬃcient amounts of one or
several dNTPs.
Interestingly, the rnr1-Y285F and rnr1-Y285A strains
did not demonstrate any cell cycle defects (Figure 3C),
despite highly imbalanced dNTP pools in rnr1-Y285A
(20- and 17-fold increased dCTP and dTTP, respectively).
The proliferation rates of the rnr1-Y285F and rnr1-Y285A
strains were similar to wild-type (Figure 3E). Further-
more, the rnr1-Y285F rnr3D and rnr1-Y285A rnr3D
strains were viable and grew normally (data not shown).
These data demonstrate that when none of the dNTPs is
limiting for DNA replication, even highly imbalanced
dNTP pools do not interfere with the cell cycle
progression.
Eﬀects of dNTP pool imbalances on Can
r mutation rates
All substitutions in loop 2 of Rnr1 increased the Can
r
mutation rates (Table 1). A separate study (Kumar,D.,
Abdulovic,A., Kunkel,T.A. and Chabes,A., submitted
for publication) strongly suggests that this is due to
decreased DNA replication ﬁdelity resulting from the
dNTP pool imbalances. Interestingly, even a mild dNTP
pool imbalance in rnr1-Y285F resulted in a  2.5-fold
increase in the mutation rate. The mutation rates were
not directly proportional to the degree of the dNTP
pool imbalance. For example, the severe imbalance in
rnr-Y285A resulted in the highest increase in the
mutation rate, while the severe imbalance in rnr1-Q288A
(the relative excess of dGTP over dCTP is  200-fold, and
the relative excess of dATP over dCTP is  80-fold)
resulted in a moderate, 4-fold increase in the mutation
rate. Thus, diﬀerent dNTP pool imbalances vary in their
mutagenic potential. However, it should be noted that the
slow cell cycle progression and/or activated S-phase
checkpoint (see below) could inﬂuence the mutation
rates in rnr1-Q288A.
Severely imbalanced dNTP pools can escape the
S-phase checkpoint
It is well established that stalling of replication forks due
to the depletion of one or several dNTPs leads to the acti-
vation of the S-phase checkpoint. The key checkpoint
protein kinases in budding yeast are Mec1 (homologue
of human ATR) and Rad53 (homologue of CHK2 and
functional homologue of CHK1 in humans). Rad53 acti-
vates a non-essential kinase Dun1, which is responsible for
the activation of RNR (3,31). In human cells, ATR and
CHK1 are upstream regulators of p53 and are mutated in
many cancers. It has been proposed that, in mammalian
cells, the ATR–CHK1-p53 S-phase checkpoint is activated
by the MMR system responding to the mis-incorporation
of deoxyribonucleotides from imbalanced pools, and not
due to the stalling of DNA synthesis (32). Therefore, it
seemed possible that the S-phase checkpoint might be
activated in the rnr1 mutant strains, either due to deple-
tion of dNTPs in rnr1-Q288A and rnr1-R293A, or due to
increased mis-incorporation of dNTPs and activation of
MMR in the rnr1-Y285F and rnr1-Y285A mutant strains.
RNR2, RNR3 and RNR4 genes are highly induced by
DNA damage or replication blocks in a Mec1–Rad53–
Dun1-dependent manner (8,13). Analysis of Rnr2, Rnr3
and Rnr4 levels were, therefore, used as a sensitive readout
of checkpoint activation (Figure 4A). Indeed, Rnr2, Rnr3
and Rnr4 protein levels were highly elevated, and there-
fore the S-phase checkpoint was activated (Figure 4B) in
the strains with depleted dNTP pools and prolonged
S-phase (rnr1-Q288A and rnr1-R293A). This result
agrees with the observation that rnr1-Q288A and rnr1-
R293A are synthetic lethal with rnr3D. Furthermore, the
non-essential Dun1 kinase was essential in rnr1-R293A
(Figure 4C), supporting the conclusion that the Mec1–
Rad53–Dun1 checkpoint pathway is activated in the
strains with limiting dNTP pools. In contrast, the Rnr2,
Rnr3 or Rnr4 levels were not elevated in the rnr1-Y285F
and rnr1-Y285A strains indicating that the S-phase check-
point was not activated in these strains (Figure 4B).
Table 1. Mutation rates in the wild-type and integrated rnr1 mutant
strains
Strain Mutation
rate ( 10
 7)
95% CI
( 10
 7)
Fold-increase
WT 4.2 1.6–4.4 1
rnr1-Y285F 10.6 9.4–11.6 2.5
rnr1-Y285A 57 43–103 13.6
rnr1-Q288A 17 12–24 4.0
rnr1-R293A 15 9.8–17 3.6
3980 Nucleic Acids Research, 2010,Vol.38, No. 12Additionally, rnr1-Y285F and rnr1-Y285A mutations were
not synthetically lethal with either rnr3D or dun1D.
Therefore, dNTP pools that are severely imbalanced but
not limiting for replication are not detected by the S-phase
checkpoint in yeast.
DISCUSSION
The present study reveals that even highly imbalanced and
highly mutagenic dNTP pools are well tolerated and do
not activate S-phase surveillance mechanisms in yeast as
long as none of the four dNTPs is limiting for replication.
An imbalanced but not limiting for replication dNTP pool
could lead to decreased proliferation and activation of the
S-phase checkpoint by at least two mechanisms. One pos-
sibility is that the DNA polymerase could idle due to the
repeated cycles of incorrect nucleotide incorporation and
exonucleolytic proofreading. Another is activation of the
S-phase checkpoint by the mismatch repair system, which
is repairing replication errors induced by the dNTP pool
imbalance. Hastak et al. (32) reported that, in the mam-
malian cells, DNA synthesis from imbalanced nucleotide
pools causes limited DNA damage that triggers ATR–
CHK1-dependent p53 activation via the mismatch repair
system. In another study, ATR kinase activation was
mediated by the mismatch repair proteins MutSa and
MutLa in response to cytotoxic O
6-methylguanine
adducts produced by the SN1-type alkylating agents (33).
Because we did not observe the S-phase checkpoint acti-
vation in the rnr1-Y285A strain, it is possible that
mismatches in yeast cells, in contrast to mismatches in
mammalian cells, do not trigger the checkpoint response.
However, the imbalanced dNTP pools in the study by
Hastak et al. were produced by N-(phosphonacetyl)-L-
aspartate (PALA) treatment. PALA starves cells for
pyrimidine nucleotides, which could increase replication
fork stalling and contribute to the activation of check-
point independently of the mismatch repair. The activa-
tion of checkpoint by the mismatch repair system in
response to the SN1-type alkylating agents involved rec-
ognition of a damaged base, O
6-me-G. It will be interest-
ing to investigate whether the elevation of pyrimidine
dNTPs and/or whether the mismatches between the
undamaged bases also will trigger a checkpoint response
in higher eukaryotes.
Another conclusion of this study is that diﬀerent sub-
stitutions in loop 2 lead to diﬀerent dNTP pool imbal-
ances in vivo. The crystal structure of Rnr1 in complex
with four cognate allosteric speciﬁcity eﬀector–substrate
pairs from Dealwis and co-workers provides some clues
to the observed changes in the dNTP pools. dGTP is the
only eﬀector that hydrogen-bonds the side chain of D287
(19). Mutation of D287 to alanine or asparagine may,
therefore, weaken the binding of dGTP, the positive
eﬀector for ADP reduction, eﬀectively leading to a rela-
tively low increase in dATP in the D287A and D287N
mutants (Figure 2C). The Q288 residue directly contacts
all substrates except GDP (19). Thus, it is plausible that
mutating Q288 will negatively aﬀect binding of all
substrates except GDP, leading to a high dGTP concen-
tration, which is exactly what we observe (Figures 2C
and 3B). dGTP is in turn a positive eﬀector for ADP
WT
WT + MMS
WT + HU
Y285F
Q288A
WT + 4-NQO
R293A
Y285A
Rnr2
Rnr4
tubulin
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WT+MMS 
rad53
Rnr3
Rnr4
tubulin
Rnr3
RNR1
dun1
RNR1
dun1
RNR1
DUN1
rnr1-R293A
DUN1
rnr1-R293A
dun1
RNR1
DUN1
rnr1-R293A
dun1
rnr1-R293A
DUN1
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rad53   + MMS
Figure 4. The S-phase checkpoint is not activated in rnr1-Y285F and rnr1-Y285A strains. (A) Rnr3 and Rnr4 proteins are indicators of the S-phase
checkpoint activation. Western blot analysis demonstrating that the increase of Rnr3 and Rnr4 levels in response to DNA damage by methyl
methane sulphonate (MMS) depends on a functional S-phase checkpoint (presence of RAD53). (B) Western blot analysis demonstrating that the
Rnr2, Rnr3 and Rnr4 levels are not elevated in rnr1-Y285F and rnr1-Y285A, whereas the Rnr2, Rnr3 and Rnr4 levels are elevated in rnr1-Q288A and
rnr1-R293A to the similar level as after treatment by DNA damaging [4-nitroquinoline oxide (4-NQO) and MMS] and replication blocking
[hydroxyurea (HU)] agents. (C) Tetrad analysis demonstrating that the rnr1-R293A strain requires DUN1 for survival.
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reduction, which may explain the relatively high dATP
levels and the relatively low dCTP and dTTP levels in
the Q288 mutants. R293 interacts with the base of the
substrate in the ADP- and GDP-bound structures
only (19). This interaction does not explain why the
levels dCTP and dTTP are aﬀected more than dATP
(Figure 3B). In the dGTP–ADP complex, the guanine
base hydrogen bonds to the bottom of loop 2, involving
main-chain atoms of Y285 (19). It is possible that
mutation of Y285 weakens the binding of dGTP, a
negative eﬀector for the reduction of CDP and UDP
and a positive eﬀector for the reduction of ADP, in turn
leading to high pyrimidine dNTPs.
A collection of yeast strains with various deﬁned dNTP
pool imbalances will be highly useful for the in vivo studies
of, for example, the ﬁdelity of nuclear and mitochondrial
DNA polymerases, the contribution of translesion
polymerases to the bypass of spontaneous DNA lesions,
and the speciﬁcity and eﬃciency of the mismatch repair
system. Saccharomyces cerevisiae is a good model system
for studying the eﬀects of mutations in RNR on the dNTP
pools balance and the dNTP-dependent processes. This is
partly because, in contrast to many bacteria and mamma-
lian cells, wild-type S. cerevisiae lack nucleoside kinases,
and therefore are unable to uptake nucleosides from the
media (34). Furthermore, S. cerevisiae has no 50-
nucleotidases that degrade nucleoside monophosphates
to nucleosides (1). In the absence of deoxyribonucleotide
degradation and excretion, and of deoxyribonucleoside
uptake, a yeast cell presents a convenient, closed
‘microreactor’ for the simultaneous assay of RNR
activity towards all four substrates.
Considering complete conservation of loop 2 between
yeast and mammalian RNRs (Figure 2A), it is likely that
mutations investigated in this study will lead to similar
dNTP pool imbalances in mammalian cells. Stable,
deﬁned dNTP pool imbalances produced by mutations
in the enzymes involved in dNTP biosynthesis are more
useful for studying replication ﬁdelity, mismatch repair
and other dNTP-dependent processes than imbalances
obtained by the addition of nucleosides, their analogues
or inhibitors of the dNTP synthesis. The exogenously
supplied nucleosides and drugs quickly change their con-
centration and are metabolized to a number of unknown
compounds, making it diﬃcult to investigate their exact
eﬀects.
We were surprised to observe only a modest, 4-fold
increase in the mutation rate in the rnr1-Q288A strain.
The relative dNTP pool imbalance in this strain is larger
than in the rnr1-Y285A strain, which has a more signiﬁ-
cant, 13.5-fold increase in the mutation rate. There are
several possible explanations to this observation: (i) a
more eﬃcient misincorporation of pyrimidine dNTPs
compared to purine dNTPs; (ii) a more eﬃcient proof-
reading in rnr1-Q288A due to the slow DNA replication
and inhibition of proofreading in rnr1-Y285A due to
the excessive dNTP pools; (iii) an increased correction
of mismatches in rnr1-Q288A due to the activated
S-phase checkpoint; and (iv) a better recognition of
misincorporated purines by the mismatch repair system.
Further studies will be required to explain the diﬀerences
in the rnr1-Q288A and rnr1-Y285A mutations rates.
The ﬁrst reports implicating mutations in human
RNR in genetic disorders were published very recently.
Mutations in the human RRM2B gene encoding an
alternative small RNR subunit were demonstrated to be
associated with mitochondrial (mt) DNA depletion
syndrome (MDS) leading to muscular dystrophy (35),
autosomal-dominant progressive external ophthal-
moplegia (adPEO) leading to weakness of the external
eye muscles and exercise intolerance (36) and mitocho-
ndrial neurogastrointestinal encephalopathy (MNGIE)
(37). The other causes of these disorders involve mutations
in the mtDNA polymerase g, mtDNA helicase Twinkle or
in the enzymes of the mitochondrial nucleotide salvage
and transport. However, a number of clinical cases
associated with these disorders remain unexplained. It
will be interesting to investigate whether mutations in
loop 2 of the human large RNR subunit are involved in
these and other genetic disorders or are early events in the
evolution of cancer cells.
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